cdmo.directory
← Compare landing

Emergent BioSolutions CDMO vs Maravai LifeSciences

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/emergentbiosolutions/maravai

CategoryEmergent BioSolutions CDMOMaravai LifeSciences
Listed sitecdmocdmo
SummaryLeading public health company specializing in medical countermeasures, commercial products, and strategic manufacturing partnerships for biodefense and public health preparedness.Leading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology.
Services
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Technology Transfer
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • Vaccine Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Quality Control Testing
  • Process Development
  • Cell-Line Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Technology Transfer
Modalities
  • Vaccine
  • Biologics (Other)
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Oligonucleotide
  • mRNA
  • Gene Therapy
  • Vaccine
Indications
  • Infectious Disease
  • Oncology
  • Neurology
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
Locations
  • Headquarters, Gaithersburg, Maryland, United States
Data not yet provided.
CertificationsData not yet provided.
  • ISO · Identifier: ISO-9001:2015
  • ISO · Identifier: ISO-9001:2015
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.